138 related articles for article (PubMed ID: 16105737)
21. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities.
Griesbeck AG; El-Idreesy TT; Höinck LO; Lex J; Brun R
Bioorg Med Chem Lett; 2005 Feb; 15(3):595-7. PubMed ID: 15664819
[TBL] [Abstract][Full Text] [Related]
22. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
23. Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore.
O'Neill PM; Mukhtar A; Ward SA; Bickley JF; Davies J; Bachi MD; Stocks PA
Org Lett; 2004 Sep; 6(18):3035-8. PubMed ID: 15330581
[TBL] [Abstract][Full Text] [Related]
24. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols.
Amewu R; Gibbons P; Mukhtar A; Stachulski AV; Ward SA; Hall C; Rimmer K; Davies J; Vivas L; Bacsa J; Mercer AE; Nixon G; Stocks PA; O'Neill PM
Org Biomol Chem; 2010 May; 8(9):2068-77. PubMed ID: 20401383
[TBL] [Abstract][Full Text] [Related]
26. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.
Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735
[TBL] [Abstract][Full Text] [Related]
27. New orally active amino- and hydroxy-functionalized 11-azaartemisinins and their derivatives with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
Singh C; Verma VP; Hassam M; Singh AS; Naikade NK; Puri SK
J Med Chem; 2014 Mar; 57(6):2489-97. PubMed ID: 24524185
[TBL] [Abstract][Full Text] [Related]
28. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
29. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
Tripathi R; Jefford CW; Dutta GP
Parasitology; 2006 Jul; 133(Pt 1):1-9. PubMed ID: 16764736
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
[TBL] [Abstract][Full Text] [Related]
31. Coumarin-trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds.
Sashidhara KV; Kumar A; Dodda RP; Krishna NN; Agarwal P; Srivastava K; Puri SK
Bioorg Med Chem Lett; 2012 Jun; 22(12):3926-30. PubMed ID: 22607674
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys.
Tripathi R; Mishra D; Rizvi A; Singh C
Life Sci; 2007 Nov; 81(21-22):1544-8. PubMed ID: 17976659
[TBL] [Abstract][Full Text] [Related]
33. Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium sp.
Lazaro JE; Nitcheu J; Mahmoudi N; Ibana JA; Mangalindan GC; Black GP; Howard-Jones AG; Moore CG; Thomas DA; Mazier D; Ireland CM; Concepcion GP; Murphy PJ; Diquet B
J Antibiot (Tokyo); 2006 Sep; 59(9):583-90. PubMed ID: 17136890
[TBL] [Abstract][Full Text] [Related]
34. Geraniol-derived 1,2,4-trioxanes with potent in-vivo antimalarial activity.
Singh C; Gupta N; Puri SK
Bioorg Med Chem Lett; 2003 Oct; 13(20):3447-50. PubMed ID: 14505646
[TBL] [Abstract][Full Text] [Related]
35. Novel amino- and hydroxy-functionalized 1,2,4-trioxanes and their antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in Swiss mice via intramuscular and oral route.
Yadav P; Naikade NK; Hassam M; Singh AS; Singh C; Puri SK; Prakash Verma V
Bioorg Med Chem Lett; 2024 Jan; 97():129561. PubMed ID: 37967655
[TBL] [Abstract][Full Text] [Related]
36. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
Shukla B; Dutta GP
J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
[No Abstract] [Full Text] [Related]
37. Unambiguous synthesis and prophylactic antimalarial activities of imidazolidinedione derivatives.
Zhang Q; Guan J; Sacci J; Ager A; Ellis W; Milhous W; Kyle D; Lin AJ
J Med Chem; 2005 Oct; 48(20):6472-81. PubMed ID: 16190773
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis of primaquine analogues and their antimalarial activity in mice].
Jiang Q; Zhong J; Shi Y; Li G
Yao Xue Xue Bao; 1998; 33(3):194-200. PubMed ID: 11938965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
